Argentarii’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$638K Buy
2,456
+15
+0.6% +$3.5K 0.19% 97
2026
Q1
$597K Sell
2,441
-346
-12% -$80.6K 0.21% 99
2025
Q4
$577K Buy
2,787
+9
+0.3% +$1.78K 0.19% 106
2025
Q3
$515K Sell
2,778
-17
-0.6% -$2.91K 0.21% 89
2025
Q2
$427K Sell
2,795
-80
-3% -$12.3K 0.2% 95
2025
Q1
$477K Buy
2,875
+40
+1% +$6.26K 0.24% 91
2024
Q4
$410K Buy
+2,835
New +$439K 0.21% 95

Other funds holding JNJ

Argentarii's JNJ Position: Q2 2026 in Review

Argentarii increased its Johnson & Johnson (JNJ) stake by 0.61% in Q2 2026, buying an estimated $3.5K and bringing the position to 2,456 shares worth $638K. The position accounts for 0.19% of the portfolio, ranked #97.

Argentarii first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Argentarii held 2,456 shares of Johnson & Johnson worth $638K as of Q2 2026.
  • Argentarii bought 15 Johnson & Johnson shares in Q2 2026, an estimated $3.5K.
  • Johnson & Johnson made up 0.19% of Argentarii's portfolio in Q2 2026, its #97 holding.
  • Argentarii first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Argentarii's 13F filing for Q2 2026, filed 12 Aug 2026.